Jørgensen Marit Eika, Kristensen Jette K, Reventlov Husted Gitte, Cerqueira Charlotte, Rossing Peter
Steno Diabetes Center, Gentofte; National Institute of Public Health, University of Southern Denmark, Odense.
Aarhus University, Aarhus.
Clin Epidemiol. 2016 Oct 25;8:429-434. doi: 10.2147/CLEP.S99518. eCollection 2016.
The aim of the Danish Adult Diabetes Registry (DADR) is to provide data from both the primary health care sector (general practice [GP]) and the secondary sector (specialized outpatient clinics) to assess the quality of treatment given to patients with diabetes. The indicators represent process and outcome indicators selected from the literature.
The total diabetes population in Denmark is estimated to be ~300,000 adult diabetes patients. Approximately 10% have type 1 diabetes, which is managed mainly in the secondary sector, and 90% have type 2 diabetes with the majority (80%) being treated in primary health care. In 2014, DADR included data from a total of 70,826 patients.
The following variables are assessed: date of analysis as well as the outcome for hemoglobin A1c, blood pressure, lipids, urinary albumin-creatinine ratio, smoking status, glucose-, blood pressure-, and lipid-lowering treatment (yes/no), insulin pump treatment (yes/no), and date of last eye and foot examination.
In 2014, the annual report included data regarding over 38,000 patients from outpatient clinics, which is assumed to have included almost all patients in this setting, and >32,000 from GPs, reflecting improved but still limited coverage from this setting. The annual results are published in a compiled report of Danish Diabetes Care, which included DADR, data from the pediatric diabetes database, and the national ophthalmological diabetes database. The annual report is published, which included data on national, regional, and local level (individual outpatient clinics and corresponding GPs). This allows a comprehensive overview of diabetes care in Denmark.
The database covers an increasing fraction of patients with diabetes in Denmark, and the structure for full coverage is in place. Annual reporting has helped to ensure focus on the quality of diabetes treatment in the primary and secondary health care. Furthermore, it is an important resource for Danish register-based diabetes research.
丹麦成人糖尿病登记处(DADR)的目的是提供来自初级卫生保健部门(全科医疗[GP])和二级部门(专科门诊)的数据,以评估糖尿病患者的治疗质量。这些指标代表了从文献中选取的过程和结果指标。
丹麦糖尿病患者总数估计约为30万成年糖尿病患者。约10%患有1型糖尿病,主要在二级部门进行管理,90%患有2型糖尿病,其中大多数(80%)在初级卫生保健机构接受治疗。2014年,DADR纳入了总共70826名患者的数据。
评估以下变量:分析日期以及糖化血红蛋白、血压、血脂、尿白蛋白-肌酐比值、吸烟状况、降糖、降压和降脂治疗(是/否)、胰岛素泵治疗(是/否)以及最后一次眼部和足部检查的日期。
2014年,年度报告包含了来自门诊诊所的38000多名患者的数据,据推测这几乎涵盖了该环境下的所有患者,以及来自全科医生的32000多名患者的数据,这反映了该环境下覆盖面有所改善但仍有限。年度结果发表在《丹麦糖尿病护理汇编报告》中,该报告包括DADR、儿科糖尿病数据库的数据以及国家眼科糖尿病数据库。年度报告已发布,其中包括国家、地区和地方层面(个体门诊诊所及相应的全科医生)的数据。这使得能够全面了解丹麦的糖尿病护理情况。
该数据库涵盖了丹麦越来越多的糖尿病患者,全面覆盖的架构已经到位。年度报告有助于确保关注初级和二级卫生保健中糖尿病治疗的质量。此外,它是丹麦基于登记处的糖尿病研究的重要资源。